Gabapentin

Gabapentin was originally designed as a structural analog of the neurotransmitter GABA (gamma-aminobutyric acid), but research has shown it does not actually work through the GABA system. Despite its name, gabapentin does not bind to GABA receptors, is not converted to GABA, and does not affect GABA uptake or degradation ^{[1, 6, 12]}.

Instead, gabapentin works primarily by binding to the alpha-2-delta (alpha2delta) subunit of voltage-gated calcium channels in the central nervous system ^{[1, 6]}. This binding reduces calcium influx at nerve terminals, which decreases the release of excitatory neurotransmitters including glutamate, norepinephrine, and substance P. The net effect is reduced nerve excitability, which helps control seizures and reduces neuropathic pain signaling ^{[1, 6]}.

Gabapentin is particularly effective for neuropathic pain — pain caused by damage or dysfunction of the nervous system itself, such as postherpetic neuralgia, diabetic peripheral neuropathy, and other nerve injury conditions ^{[1, 3, 4]}. This type of pain often does not respond well to traditional painkillers like NSAIDs or opioids. Landmark trials by Rowbotham et al. and Backonja et al. established gabapentin's efficacy for postherpetic neuralgia and diabetic neuropathy, respectively ^{[3, 4]}.

Gabapentin has become one of the most prescribed medications in the United States, with over 65 million prescriptions annually ^[11]. However, most prescriptions are for off-label uses, as its only FDA-approved indications are partial seizures and postherpetic neuralgia. The extensive off-label use has raised questions about appropriate prescribing in some contexts ^{[8, 11]}.

Gabapentin is started at a low dose and gradually increased (titrated) over 1-3 weeks to minimize side effects, particularly dizziness and sedation ^[1].

For postherpetic neuralgia, a typical titration schedule is: 300 mg on Day 1, 300 mg twice daily on Day 2, 300 mg three times daily on Day 3, then increase as needed up to 1,800 mg/day (divided into three doses). Some patients need up to 3,600 mg/day ^{[1, 3]}.

The most common early side effects are dizziness, drowsiness, and fatigue ^[1]. These typically improve over the first 1-2 weeks as your body adjusts. Starting low and increasing slowly helps. The FDA boxed-warning-level safety communication warns that combining gabapentin with opioids, benzodiazepines, or other CNS depressants can cause serious respiratory depression ^[2].

Pain relief from gabapentin may take 1-2 weeks to begin and 3-8 weeks to reach full effect ^{[1, 3, 4]}. Some patients respond quickly; others need several weeks of dose optimization.

Gabapentin must be taken three times daily due to its short half-life (5-7 hours). Extended-release formulations (Gralise, Horizant) allow less frequent dosing ^[1].

One unique aspect of gabapentin is its saturable absorption — higher single doses are absorbed less efficiently ^{[1, 7]}. This means splitting the daily dose into three portions is important for consistent drug levels.

Gabapentin immediate-release can be taken with or without food. The extended-release formulation (Gralise) should be taken with food to improve absorption ^[1].

Alcohol: Alcohol should be avoided or strictly limited. Both gabapentin and alcohol are CNS depressants, and their combination significantly increases the risk of excessive sedation, impaired coordination, falls, and respiratory depression ^{[1, 2]}. This is especially dangerous for elderly patients and those also taking opioids ^{[2, 9]}.

No significant food interactions with the immediate-release formulation, though taking it with food may slightly improve absorption consistency ^[1].

Antacids: Gabapentin absorption is reduced by approximately 20% when taken within 2 hours of aluminum/magnesium-containing antacids. Take gabapentin at least 2 hours after antacid use ^[1].

Gabapentin dosing varies by indication and requires titration. It is typically given three times daily due to its short half-life ^[1].

Postherpetic Neuralgia (adults) [1, 3]: - Day 1: 300 mg once - Day 2: 300 mg twice daily - Day 3: 300 mg three times daily - Titrate up to 1,800 mg/day (600 mg TID) as needed - Maximum: 3,600 mg/day (1,200 mg TID)

Partial Seizures (adults, adjunctive) [1]: - Starting dose: 300 mg three times daily - Effective range: 900-3,600 mg/day in three divided doses - Maximum interval between doses: 12 hours

Pediatric Seizures (ages 3-12) [1]: - Starting: 10-15 mg/kg/day in three divided doses - Range: 25-35 mg/kg/day in three divided doses

Renal Dosing (critical — gabapentin is renally eliminated) [1]: - CrCl 30-59: 200-700 mg BID - CrCl 15-29: 200-700 mg once daily - CrCl <15: 100-300 mg once daily - Hemodialysis: supplemental dose after each dialysis session

Important [1]: Do not exceed 12-hour gap between doses (seizure indication). Take at evenly spaced intervals.

Discontinuation [1, 10]: Taper over at least 1 week. Do not stop abruptly, especially in seizure patients — abrupt withdrawal can trigger seizures.

Gabapentin is available as an inexpensive generic, though pricing varies across formulations ^{[1, 12]}.

Generic IR pricing: Generic gabapentin capsules/tablets cost approximately $5-$20 per month at most pharmacies. Available on many $4 generic lists for lower doses.

Brand Neurontin: Rarely prescribed as brand; costs $200-$500/month. No advantage over generic ^[1].

Extended-release formulations: Gralise ($300-$500/month) and Horizant ($400-$600/month) are significantly more expensive and are NOT interchangeable with generic gabapentin IR ^[1]. Generic gabapentin IR taken three times daily is equally effective for most patients.

Insurance: Generic gabapentin is Tier 1 on most formularies. Extended-release formulations may require prior authorization.

Cost concern: Despite being cheap per pill, high-dose gabapentin (e.g., 3,600 mg/day = nine 400-mg capsules daily) means more pills per month. Even so, the monthly cost remains under $20-$30 for most patients.

Gabapentin has some abuse/misuse potential, and some states have scheduled it as a controlled substance ^[8]. This may affect prescription practices but does not affect the drug's cost.

Pregnancy: Gabapentin is not well-studied in human pregnancy ^[1]. Animal studies at high doses showed fetal skeletal and organ abnormalities, but these doses were much higher than human therapeutic doses ^[1]. The limited human data from registry studies have not shown a clear pattern of birth defects, but data are insufficient to confirm safety.

If gabapentin is needed for seizure control during pregnancy, the risk of uncontrolled seizures must be weighed against potential fetal risks. Gabapentin is generally not first-line during pregnancy ^[1]. All women taking antiepileptic drugs should take folic acid supplementation.

Breastfeeding: Gabapentin is excreted in breast milk, with infant doses estimated at 1-4% of the maternal weight-adjusted dose ^[1]. Limited clinical reports have not identified adverse effects in breastfed infants, but data are limited. LactMed considers it probably compatible with breastfeeding. Monitor the infant for drowsiness and adequate feeding ^[1].

Generic gabapentin (immediate-release capsules and tablets) has been available since 2004 ^[1]. It is the standard.

- Generic gabapentin IR: $5-$20/month. Multiple manufacturers. FDA AB-rated ^[1]. - Brand Neurontin: $200-$500/month. Same drug. - Gralise (ER, once-daily for PHN): Not generically available; $300-$500/month. Different release profile — NOT substitutable with generic IR ^[1]. - Horizant (gastroretentive, once/twice daily): Not generically available; $400-$600/month. Gabapentin enacarbil (prodrug) — NOT interchangeable with gabapentin ^[1].

For most patients, generic gabapentin IR taken three times daily is the most cost-effective option.